HB103 Alabama 2011 Session

Summary

Primary Sponsor

Mike Ball

Republican

Co-Sponsors

Wayne JohnsonKen JohnsonWes LongEd HenryKerry RichHoward SanderfordRandy WoodJim McClendonDaniel H. Boman

Session

Regular Session 2011

Title

Ephedrine, pseudoephedrine, and phenylpropanolamine, State Board of Health required to classify as controlled substances, exemptions, removed from list of precursor chemicals maintained by State Board of Pharmacy, Secs. 20-2-20, 20-2-181 am'd.

Summary

HB103 would require classification of ephedrine, pseudoephedrine, and phenylpropanolamine as Schedule III controlled substances and regulate their sale, with possible exemptions for products designed to prevent methamphetamine production.

What This Bill Does

The State Board of Health would classify the three substances as Schedule III controlled substances, meaning they would be sold by prescription. The Board could exempt a product containing any of these substances from control if the product is effectively formulated to prevent conversion to methamphetamine, and the Board could revoke that exemption if the Department of Public Safety indicates the product is no longer effective, with an emergency rule possible pending a hearing. If federal scheduling changes occur, Alabama would mirror those changes after 30 days unless the Board objects and holds a hearing. The bill also adds these chemicals to the state's listed precursor chemicals list, with a transitional provision until the Board of Pharmacy adopts formal rules.

Who It Affects

• Consumers/public buyers would likely need a prescription to purchase products containing these ingredients, reducing over-the-counter access.
• Manufacturers and retailers of products containing these ingredients would must comply with scheduling rules and could seek or lose exemptions for their products based on formulation and safety determinations.

Key Provisions

• Classification: Ephedrine, pseudoephedrine, and phenylpropanolamine would be Schedule III controlled substances under Alabama law, requiring prescription sales.
• Exemption mechanism: The State Board of Health may exempt a product containing these substances from classification if it is effectively formulated to prevent conversion to methamphetamine; the Board may revoke the exemption upon notification by the Department of Public Safety that the product is no longer effectively formulated, with an emergency rule valid pending a hearing.
• Federal mirroring: If federal law designates or reschedules these substances, Alabama would similarly control them after 30 days from federal action unless the Board objects and holds a hearing.
• Precursor list: The Board of Pharmacy would list these chemicals as listed precursor chemicals; until the Board adopts formal rules, they are deemed listed precursors under the bill.
• Effective date: The act becomes effective on the first day of the third month following its passage and approval.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Controlled Substances